dementia

Leqembi and Kisunla slow Alzheimer's progression by 27–35%. Here's what science finally knows about amyloid, tau, blood biomarkers, and the 14 modifiable risk factors.

How amyloid plaques, tau tangles, and neuronal death drive Alzheimer's—plus new blood tests, FDA-approved drugs, and prevention evidence.